179 related articles for article (PubMed ID: 9895043)
21. [Electrogastrography monitoring of the effectiveness of prokinetic and cognitive therapy in functional dyspepsia].
Fodor G; Schwab R; Gyökeres T; Pap A
Orv Hetil; 2005 Jun; 146(26):1393-7. PubMed ID: 16052981
[TBL] [Abstract][Full Text] [Related]
22. Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying.
Wilmer A; Van Cutsem E; Andrioli A; Tack J; Coremans G; Janssens J
Gut; 1998 Feb; 42(2):235-42. PubMed ID: 9536949
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying].
Portincasa P; Mearin F; Robert M; Plazas MJ; Mas M; Heras J
Gastroenterol Hepatol; 2009 Dec; 32(10):669-76. PubMed ID: 19819042
[TBL] [Abstract][Full Text] [Related]
24. Treatment of uninvestigated dyspepsia with cisapride for patients with negative Helicobacter pylori serologies.
Kearney DJ; Avins AL; McQuaid KR
Am J Gastroenterol; 2000 Sep; 95(9):2212-7. PubMed ID: 11007220
[TBL] [Abstract][Full Text] [Related]
25. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia.
Holtmann G; Gschossmann J; Karaus M; Fischer T; Becker B; Mayr P; Gerken G
Aliment Pharmacol Ther; 1999 Nov; 13(11):1459-65. PubMed ID: 10571602
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
[TBL] [Abstract][Full Text] [Related]
27. Effect of glyceryl trinitrate on gastric accommodation and symptoms in functional dyspepsia.
Gilja OH; Hausken T; Bang CJ; Berstad A
Dig Dis Sci; 1997 Oct; 42(10):2124-31. PubMed ID: 9365147
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound measurement of gastric emptying time in patients with cystic fibrosis and effect of ranitidine on delayed gastric emptying.
Cucchiara S; Raia V; Minella R; Frezza T; De Vizia B; De Ritis G
J Pediatr; 1996 Apr; 128(4):485-8. PubMed ID: 8618181
[TBL] [Abstract][Full Text] [Related]
29. Effects of oral erythromycin on fasting and postprandial antroduodenal motility in patients with type I diabetes, measured with an ambulatory manometric technique.
Samsom M; Jebbink RJ; Akkermans LM; Bravenboer B; vanBerge-Henegouwen GP; Smout AJ
Diabetes Care; 1997 Feb; 20(2):129-34. PubMed ID: 9118759
[TBL] [Abstract][Full Text] [Related]
30. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.
Rezende-Filho J; Di Lorenzo C; Dooley CP; Valenzuela JE
Dig Dis Sci; 1989 Jul; 34(7):1057-62. PubMed ID: 2743845
[TBL] [Abstract][Full Text] [Related]
31. The influence of cisapride on gastric tone and the perception of gastric distension.
Tack J; Broeckaert D; Coulie B; Janssens J
Aliment Pharmacol Ther; 1998 Aug; 12(8):761-6. PubMed ID: 9726390
[TBL] [Abstract][Full Text] [Related]
32. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
Madisch A; Heydenreich CJ; Wieland V; Hufnagel R; Hotz J
Arzneimittelforschung; 1999 Nov; 49(11):925-32. PubMed ID: 10604046
[TBL] [Abstract][Full Text] [Related]
33. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
[TBL] [Abstract][Full Text] [Related]
34. Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study.
Frazzoni M; Lonardo A; Grisendi A; Della Casa G; Pulvirenti M; Ferrari AM; Di Gregorio C; Melini L
J Clin Gastroenterol; 1993 Sep; 17(2):101-8. PubMed ID: 8409311
[TBL] [Abstract][Full Text] [Related]
35. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
[TBL] [Abstract][Full Text] [Related]
36. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
[TBL] [Abstract][Full Text] [Related]
37. Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial.
Chung JM
Scand J Gastroenterol Suppl; 1993; 195():11-4. PubMed ID: 8516653
[TBL] [Abstract][Full Text] [Related]
38. Gastric emptying and antral motility parameters in children with functional dyspepsia: association with symptom severity.
Devanarayana NM; Rajindrajith S; Perera MS; Nishanthanie SW; Benninga MA
J Gastroenterol Hepatol; 2013 Jul; 28(7):1161-6. PubMed ID: 23517336
[TBL] [Abstract][Full Text] [Related]
39. Prokinetic effect of gut-oriented hypnosis on gastric emptying.
Chiarioni G; Vantini I; De Iorio F; Benini L
Aliment Pharmacol Ther; 2006 Apr; 23(8):1241-9. PubMed ID: 16611286
[TBL] [Abstract][Full Text] [Related]
40. [Fasting and postprandial antroduodenal motility in functional dyspepsia].
Zhang S; Wang Z
Zhonghua Nei Ke Za Zhi; 1995 Aug; 34(8):536-9. PubMed ID: 8697913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
